Managing Capivasertib Side Effects: Strategies for Educating, Monitoring, and Addressing Rash and Hyperglycemia

Panelists discuss their approach to monitoring and managing hyperglycemia in patients receiving capivasertib and providing education about it, including when to involve endocrinology and how management strategies may differ for patients with preexisting diabetes.

EP: 1.Insights on Biomarker Testing in HR+/HER2- Advanced Breast Cancer

EP: 2.First-Line Treatment Strategies for HR+/HER2- Advanced Breast Cancer

EP: 3.Role of PI3K/AKT/PTEN Pathway in HR+/HER2- Advanced Breast Cancer

EP: 4.Overview of the CAPItello-291 Trial

EP: 5.Clinical Experience with Capivasertib

EP: 6.Adverse Event Management: Strategies for Reducing Diarrhea Risk in Capivasertib Therapy

Now Viewing

EP: 7.Managing Capivasertib Side Effects: Strategies for Educating, Monitoring, and Addressing Rash and Hyperglycemia

EP: 8.Best Practices in Managing Patients on Capivasertib

Video content above is prompted by the following:

1. All faculty: What is your approach to monitoring and managing hyperglycemia and providing education about it?

• When would you involve endocrinology?
• How might this change if a patient has preexisting diabetes?

Related Videos